Trial intelligence / Profile preview

Comparison of Insulin Aspart, BIAsp 70, BIAsp 50, and Human Insulin in Type 1 Diabetes

NCT00888732Phase 3Completed

Sponsor
Aarhus University
Start
Jun 2009
Primary completion
Jun 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of insulin aspart, Insulin aspart + insulin aspart protamine, human insulin in type 1 diabetes mellitus (T1D), sponsored by Aarhus University. Started Jun 2009; status: completed.

02

Drugs

insulin aspartInsulin aspart + insulin aspart protaminehuman insulin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00888732.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00888732.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call